Cite

HARVARD Citation

    Ashton, V. et al. (2021). The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations. Journal of clinical pharmacology. pp. 1010-1026. [Online]. 
  
Back to record